Conference
THU0067 Is Treat-To-Target Really Working? A Longitudinal Analysis in Biodam
Abstract
Background A Treat-to-Target approach (T2T), treating patients with RA towards a target, either remission or low disease activity (T2T-REM or T2T-LDA) is nowadays recommended. However it has never been assessed whether such a strategy in daily clinical practice really leads to more patients meeting that target. Methods BIODAM is a 2-year prospective cohort including patients in daily practice with RA from 10 countries, who were started or …
Authors
Ramiro S; Landewé R; van der Heijde D; FitzGerald O; Østergaard M; Homik J; Elkayam O; Thorne JC; Larche M; Ferraccioli G
Volume
75
Pagination
pp. 202-203
Publisher
Elsevier
Publication Date
June 2016
DOI
10.1136/annrheumdis-2016-eular.1914
Conference proceedings
Annals of the Rheumatic Diseases
ISSN
0003-4967